BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29803118)

  • 1. Expression profile and cellular localizations of mucin proteins, CK7, and cytoplasmic p27 in Barrett's esophagus and esophageal adenocarcinoma.
    Ozcan HEA; Anuk T; Ozden O
    Adv Med Sci; 2018 Sep; 63(2):296-300. PubMed ID: 29803118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of C1q complement component in Barrett's esophagus and esophageal adenocarcinoma.
    Bobryshev YV; Lu J; Lord RV
    J Gastrointest Surg; 2010 Aug; 14(8):1207-13. PubMed ID: 20496011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of lineage-uncommitted, long-lived, label-retaining cells in healthy human esophagus and stomach, and in metaplastic esophagus.
    Pan Q; Nicholson AM; Barr H; Harrison LA; Wilson GD; Burkert J; Jeffery R; Alison MR; Looijenga L; Lin WR; McDonald SA; Wright NA; Harrison R; Peppelenbosch MP; Jankowski JA
    Gastroenterology; 2013 Apr; 144(4):761-70. PubMed ID: 23266557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells in Barrett's esophagus and esophageal adenocarcinoma.
    Bobryshev YV; Tran D; Killingsworth MC; Buckland M; Lord RV
    J Gastrointest Surg; 2009 Jan; 13(1):44-53. PubMed ID: 18685901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole genome expression array profiling highlights differences in mucosal defense genes in Barrett's esophagus and esophageal adenocarcinoma.
    Nancarrow DJ; Clouston AD; Smithers BM; Gotley DC; Drew PA; Watson DI; Tyagi S; Hayward NK; Whiteman DC; ;
    PLoS One; 2011; 6(7):e22513. PubMed ID: 21829465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocrine VEGF signaling promotes proliferation of neoplastic Barrett's epithelial cells through a PLC-dependent pathway.
    Zhang Q; Yu C; Peng S; Xu H; Wright E; Zhang X; Huo X; Cheng E; Pham TH; Asanuma K; Hatanpaa KJ; Rezai D; Wang DH; Sarode V; Melton S; Genta RM; Spechler SJ; Souza RF
    Gastroenterology; 2014 Feb; 146(2):461-72.e6. PubMed ID: 24120473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDX-2 Expression in Esophageal Biopsies Without Goblet Cell Intestinal Metaplasia May Be Predictive of Barrett's Esophagus.
    Saller J; Al Diffalha S; Neill K; Bhaskar RA; Oliveri C; Boulware D; Levine H; Kalvaria I; Corbett FS; Khazanchi A; Klapman J; Coppola D
    Dig Dis Sci; 2020 Jul; 65(7):1992-1998. PubMed ID: 31691172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crypt dysplasia in Barrett's oesophagus shows clonal identity between crypt and surface cells.
    Khan S; McDonald SA; Wright NA; Graham TA; Odze RD; Rodriguez-Justo M; Zeki S
    J Pathol; 2013 Sep; 231(1):98-104. PubMed ID: 23695891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forkhead box F1 induces columnar phenotype and epithelial-to-mesenchymal transition in esophageal squamous cells to initiate Barrett's like metaplasia.
    De A; Zhou J; Liu P; Huang M; Gunewardena S; Mathur SC; Christenson LK; Sharma M; Zhang Q; Bansal A
    Lab Invest; 2021 Jun; 101(6):745-759. PubMed ID: 33495575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maspin differential expression patterns as a potential marker for targeted screening of esophageal adenocarcinoma/gastroesophageal junction adenocarcinoma.
    Dzinic SH; Mahdi Z; Bernardo MM; Vranic S; Beydoun H; Nahra N; Alijagic A; Harajli D; Pang A; Saliganan DM; Rahman AM; Skenderi F; Hasanbegovic B; Dyson G; Beydoun R; Sheng S
    PLoS One; 2019; 14(4):e0215089. PubMed ID: 31002675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-generation sequencing of endoscopic biopsies identifies ARID1A as a tumor-suppressor gene in Barrett's esophagus.
    Streppel MM; Lata S; DelaBastide M; Montgomery EA; Wang JS; Canto MI; Macgregor-Das AM; Pai S; Morsink FH; Offerhaus GJ; Antoniou E; Maitra A; McCombie WR
    Oncogene; 2014 Jan; 33(3):347-57. PubMed ID: 23318448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low glutathione and glutathione S-transferase levels in Barrett's esophagus as compared to normal esophageal epithelium.
    van Lieshout EM; Tiemessen DM; Witteman BJ; Jansen JB; Peters WH
    Jpn J Cancer Res; 1999 Jan; 90(1):81-5. PubMed ID: 10076569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular phenotyping reveals the identity of Barrett's esophagus and its malignant transition.
    Nowicki-Osuch K; Zhuang L; Jammula S; Bleaney CW; Mahbubani KT; Devonshire G; Katz-Summercorn A; Eling N; Wilbrey-Clark A; Madissoon E; Gamble J; Di Pietro M; O'Donovan M; Meyer KB; Saeb-Parsy K; Sharrocks AD; Teichmann SA; Marioni JC; Fitzgerald RC
    Science; 2021 Aug; 373(6556):760-767. PubMed ID: 34385390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomere Shortening of Barrett's Esophagus and Esophageal Adenocarcinoma in Japanese Patients.
    Tahara T; Shijimaya T; Yamazaki J; Tomiyama T; Fukui T; Naganuma M
    Cancer Invest; 2023 Sep; 41(7):640-645. PubMed ID: 37548421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The stem cell organisation, and the proliferative and gene expression profile of Barrett's epithelium, replicates pyloric-type gastric glands.
    Lavery DL; Nicholson AM; Poulsom R; Jeffery R; Hussain A; Gay LJ; Jankowski JA; Zeki SS; Barr H; Harrison R; Going J; Kadirkamanathan S; Davis P; Underwood T; Novelli MR; Rodriguez-Justo M; Shepherd N; Jansen M; Wright NA; McDonald SA
    Gut; 2014 Dec; 63(12):1854-63. PubMed ID: 24550372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy levels are elevated in barrett's esophagus and promote cell survival from acid and oxidative stress.
    Kong J; Whelan KA; Laczkó D; Dang B; Caro Monroig A; Soroush A; Falcone J; Amaravadi RK; Rustgi AK; Ginsberg GG; Falk GW; Nakagawa H; Lynch JP
    Mol Carcinog; 2016 Nov; 55(11):1526-1541. PubMed ID: 26373456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell-associated immune inflammation of cardiac mucosa: a possible factor in the formation of Barrett's esophagus.
    Bobryshev YV; Tran D; Killingsworth MC; Buckland M; Lord RV
    J Gastrointest Surg; 2009 Mar; 13(3):442-50. PubMed ID: 19015928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the Diagnosis and Treatment of Barrett's Esophagus and Early Esophageal Cancer; Summary of the Kelly and Carlos Pellegrini SSAT/SAGES Luncheon Symposium.
    Gould JC; Wendling MR; Oeschlager BK; Mittal SK; Komanduri S; Perry KA; Cleary S; Galandiuk S; Scott DJ; Fisichella PM; Shaheen NJ; Haisley KR; Hunter JG
    J Gastrointest Surg; 2017 Aug; 21(8):1342-1349. PubMed ID: 28243981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical localization of glutathione S-transferase alpha and pi in human esophageal squamous epithelium, Barrett's epithelium and carcinoma.
    van Lieshout EM; van Haelst UJ; Wobbes T; Peters WH
    Jpn J Cancer Res; 1999 May; 90(5):530-5. PubMed ID: 10391093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase (MMP)-7 in Barrett's esophagus and esophageal adenocarcinoma: expression, metabolism, and functional significance.
    Garalla HM; Lertkowit N; Tiszlavicz L; Reisz Z; Holmberg C; Beynon R; Simpson D; Varga A; Kumar JD; Dodd S; Pritchard DM; Moore AR; Rosztóczy AI; Wittman T; Simpson A; Dockray GJ; Varro A
    Physiol Rep; 2018 May; 6(10):e13683. PubMed ID: 29845775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.